INTRODUCTION
============

The nuclear lamina, an intermediate-filament meshwork beneath the inner nuclear membrane, provides a structural scaffold for the cell nucleus ([@B33]; [@B4]). The main protein components of the nuclear lamina are lamins A, C, B1, and B2 ([@B11]; [@B33]; [@B4]). Lamins A and C (A-type lamins) are splice isoforms from the same gene (*LMNA*; [@B16]) and are not expressed until late in embryonic development ([@B25]; [@B6]; [@B4]). *Lmna*-knockout mice survive development but die between 2 and 6 wk of age with myopathy and cardiomyopathy ([@B28]). Lamins B1 and B2 (B-type lamins) are products of independent genes, *LMNB1* and *LMNB2* ([@B37]; [@B3]; [@B17]; [@B19]; [@B33]). Lamins B1 and B2 are ∼60% identical at the amino acid level ([@B7]) and are expressed ubiquitously from the earliest stages of development. For years, dogma held that the B-type lamins played essential functions in the cell nucleus (e.g., DNA replication, formation of the mitotic spindle; [@B1]; [@B24]; [@B12]; [@B30]; [@B20], [@B21], [@B22]; [@B27]; [@B29]; [@B23]), but recent studies with tissue-specific knockout mice cast doubt on that view---at least for certain cell types. For example, the absence of *both* lamins B1 and B2 in keratinocytes or hepatocytes does not lead to any obvious abnormalities ([@B34], [@B35]).

We previously showed that lamins B1 and B2 have important functions in the developing brain ([@B31]; [@B5], [@B6]). *Lmnb2*-deficient mice were nearly normal in size during development but died soon after birth with a neuronal layering defect in the cerebral cortex. Neuronal birthdating studies demonstrated that the layering defect was due to defective neuronal migration from the ventricular zone to the cortical plate ([@B5]). *Lmnb2*-deficient fibroblasts grew normally and did not have misshapen nuclei. *Lmnb1*-deficient mice ([@B31]) survived development but were small and died soon after birth with a neuronal layering defect in the cerebral cortex ([@B6]). The neurodevelopmental defects in *Lmnb1-*deficient mice were more severe than those in *Lmnb2*-deficient mice ([@B5], [@B6]). *Lmnb1*-deficient fibroblasts had multiple nuclear blebs ([@B31]). Studies with forebrain-specific knockout mice revealed that both lamins B1 and B2 are also important for survival of cortical neurons ([@B6]).

The fact that lamins B1 and B2 have similar sequences and expression patterns, along with the fact that *Lmnb1*- and *Lmnb2*-knockout mice have similar neurodevelopmental defects, naturally leads to the question of whether lamins B1 and B2 have redundant functions. The best way to assess functional redundancy in closely related proteins is to determine whether increased production of one protein can prevent the disease phenotypes associated with loss of the other ([@B32]; [@B10]; [@B26]). In the present study, we adopted this approach. We generated two strains of reciprocal knock-in mice---one knock-in line producing lamin B2 from the *Lmnb1* locus and another producing lamin B1 from the *Lmnb2* locus. These new knock-in mouse models provided fresh, definitive insights regarding the functional redundancy of the B-type lamins in mammals.

RESULTS
=======

*Lmnb1*^B2/B2^ mice
-------------------

We used gene targeting to insert a lamin B2 cDNA (3287 base pairs) into the translational start site of exon 1 of *Lmnb1* (generating the *Lmnb1*^B2^ allele); this allele was designed to eliminate *Lmnb1* transcripts and produce lamin B2 from the *Lmnb1* promoter ([Figure 1A](#F1){ref-type="fig"}). Targeted embryonic stem (ES) cell clones were identified by long-range PCR ([Figure 1, B and C](#F1){ref-type="fig"}) and real-time PCR (RT-PCR; [Figure 1D](#F1){ref-type="fig"}). Sequencing of the *Lmnb1*^B2^ RT-PCR product identified the junction between the *Lmnb1* 5′ untranslated region (UTR) and the *Lmnb2* protein-coding sequences ([Figure 1E](#F1){ref-type="fig"}).

![Generation of the *Lmnb1*^B2^ allele, which yields lamin B2 from the *Lmnb1* locus. (A) Map of the *Lmnb1* locus and the targeting vector, which was designed to introduce a *Lmnb2* cDNA into the translational start site in exon 1 of *Lmnb1* (at an *Nco*I site). The *Lmnb2* cDNA was modified to introduce a new *Eco*RV site and remove an existing *Sac*I site (depicted by an asterisk), making it possible to distinguish *Lmnb1*^B2^ transcripts from those of the endogenous *Lmnb2* locus. Exons are depicted as black boxes (E1 and E2); the noncoding region of exon 1 is in white. Black arrowheads indicate the *loxP* sites. The *neo* cassette is shown as a gray box; a diphtheria toxin (DTA) counterselection cassette is shown as a black box. The primers used for recombineering (GF, GR, LF, and LR) are indicated. The primers used for 5′ long-range PCR (5′ LR-PCR) and 3′ long-range PCR (3′ LR-PCR) are indicated by arrows. (B) Screening of ES cell clones by 5′ long-range PCR. A 5.8-kb fragment was amplified from the *Lmnb1*^B2^ allele; the identity of the fragment was confirmed by *Eco*RV digestion (yielding 5.4-and 0.4-kb fragments). (C) Screening of ES cell clones by 3′ long-range PCR. A 6-kb DNA fragment was amplified from the *Lmnb1*^B2^ allele; the identity of the fragment was confirmed with *Bam*HI digestion (yielding 4.3- and 1.7-kb fragments). A nonspecific band is indicated by an asterisk. (D) *Eco*RV digestion of a 950--base pair *Lmnb2* RT-PCR fragment (amplicon from exons 1--7 of *Lmnb2*) from *Lmnb1*^B2/+^ and *Lmnb1*^+/+^ ES cells. *Lmnb2* RT-PCR DNA fragments from the *Lmnb1*^B2^ allele (but not from the endogenous *Lmnb2* allele) were cleaved by *Eco*RV (yielding an 850--base pair fragment). (E) DNA sequencing chromatogram of an RT-PCR fragment from the *Lmnb1*^B2^ allele showing the junction between the *Lmnb1* 5′ UTR and *Lmnb2* coding DNA sequences (CDS).](1666fig1){#F1}

Because *Lmnb1*^B2/B2^ mice produce lamin B2 transcripts from both *Lmnb1*^B2^ and *Lmnb2*, we predicted that lamin B2 expression in these mice would be greater than in wild-type mice. Indeed, *Lmnb2* transcript levels in the cerebral cortex of *Lmnb1*^B2/B2^ mice were \>2.61 ± 0.32--fold higher than in wild-type mice ([Figure 2A](#F2){ref-type="fig"}). Similar findings were observed at the protein level; lamin B2 levels in the cerebral cortex of *Lmnb1*^B2/B2^ mice were 3.01 ± 0.16--fold higher than in wild-type mice ([Figure 2, B and C](#F2){ref-type="fig"}).

![Levels of lamin transcripts and proteins in the cerebral cortex of E18.5 *Lmnb1*^B2/B2^ embryos. (A) Lamin transcript levels in the cerebral cortex of *Lmnb1*^+/+^, *Lmnb1*^B2/B2^, and *Lmnb1*^^−/−^^ embryos by quantitative RT-PCR. Transcript levels (mean ± SD) were normalized to cyclophilin A and compared with the levels in *Lmnb1*^+/+^ mice (set at 1.0). *Lmnb2* transcript levels in *Lmnb1*^B2/B2^ embryos were higher than those in *Lmnb1*^+/+^ embryos (*p* = 0.006). *Lmnb1* transcripts were undetectable in *Lmnb1*^B2/B2^ embryos. (B) Western blot of protein extracts from cerebral cortex biopsies of E18.5 *Lmnb1*^+/+^, *Lmnb1*^B2/B2^, *Lmnb1*^−/−^ embryos (the same embryos analyzed in A). Actin was used as a loading control. (C) Quantification of lamin protein levels for the Western blot in B relative to actin (mean ± SD) and compared with levels in wild-type mice (set at 1.0). Lamin B2 protein levels in the cerebral cortex were higher in *Lmnb1*^B2/B2^ embryos than in *Lmnb1*^+/+^ embryos (*p* = 0.018). Lamin B1 was undetectable in *Lmnb1*^B2/B2^ embryos.](1666fig2){#F2}

*Lmnb1*^B2/B2^ mice were small and died within 1 h of birth. However, the abnormalities in *Lmnb1*^B2/B2^ mice were less severe than in *Lmnb1*^−/−^ mice ([Figure 3](#F3){ref-type="fig"}). The body weights of embryonic day 18.5 (E18.5) *Lmnb1*^B2/B2^ embryos (0.86 ± 0.12 g; *n* = 10) were 28.4 ± 0.04% lower than those of wild-type littermate mice (1.20 ± 0.14 g; *n* = 22; *p* \< 0.001), but they were 23.4% higher than those of *Lmnb1*^−/−^ embryos (0.69 ± 0.08 g; *n* = 5; *p* = 0.007). The brain weights in the *Lmnb1*^B2/B2^ embryos (0.05 ± 0.01 g) were 55.5 ± 0.05% lower than in wild-type embryos (0.09 ± 0.01 g, *p* \< 0.001) but 62.8% higher than in *Lmnb1*^−/−^ embryos (0.03 ± 0.01 g, *p* \< 0.001; [Figure 3A](#F3){ref-type="fig"} and Supplemental Table S1). Hematoxylin and eosin--stained brain sections revealed a neuronal layering defect in the cerebral cortex of both *Lmnb1*^−/−^ and *Lmnb1*^B2/B2^ embryos, but the density of neurons was significantly higher in *Lmnb1*^B2/B2^ brains than in *Lmnb1*^−/−^ brains ([Figure 3, B and C](#F3){ref-type="fig"}). Neuronal layering defects were also apparent by immunohistochemistry with antibodies against Cux1 and Ctip2 (Supplemental Figure S1). Immunohistochemistry studies on the putamen of *Lmnb1*^B2/B2^ mice revealed higher-than-normal levels of lamin B2 expression and absent expression of lamin B1 ([Figure 3D](#F3){ref-type="fig"}).

![Phenotypes of *Lmnb1*^B2/B2^ mice. (A) Photographs of E18.5 *Lmnb1*^+/+^, *Lmnb1*^B2/B2^, and *Lmnb1*^−/−^ embryos and the brains from these mice. Scale bar, 2 mm. (B) Hematoxylin and eosin--stained sagittal sections of brains from E18.5 embryos. Scale bar, 500 μm. (C) Higher-magnification images of the boxed areas in B, showing abnormal layering of cortical neurons in *Lmnb1*^B2/B2^ mice. Scale bar, 100 μm. (D) Immunofluorescence microscopy of the putamen in E18.5 *Lmnb1*^+/+^ and *Lmnb1*^B2/B2^ embryos with antibodies against lamin B1 (green) and lamin B2 (red). Merged images show DAPI (blue) staining. Scale bar, 50 μm.](1666fig3){#F3}

*Lmnb2*^B1/B1^ mice
-------------------

We inserted a lamin B1 cDNA (2516 base pairs) at the translational start site within exon 1 of *Lmnb2* (generating the *Lmnb2*^B1^ allele). The *Lmnb2*^B1^ allele was designed to eliminate *Lmnb2* transcripts and drive the expression of lamin B1 ([Figure 4A](#F4){ref-type="fig"}). Targeted ES cell clones were identified by long-range PCR ([Figure 4, B and C](#F4){ref-type="fig"}) and RT-PCR ([Figure 4D](#F4){ref-type="fig"}). Sequencing of an RT-PCR product from the *Lmnb2*^B1^ allele revealed the junction between *Lmnb2*'s 5′-UTR and the *Lmnb1* protein-coding sequences ([Figure 4E](#F4){ref-type="fig"}).

![Generation of the *Lmnb2*^B1^ allele, which yields lamin B1 from the *Lmnb2* locus. (A) Map of the *Lmnb2* locus and the targeting vector, which was designed to introduce a *Lmnb1* cDNA into the translational start site in exon 1 of *Lmnb2* (at an *Nco*I site). A novel *Bgl*II site was introduced into the *Lmnb1* cDNA and an existing *Not*I site (depicted by an asterisk) was eliminated, making it possible to identify *Lmnb1* transcripts originating from the *Lmnb2*^B1^ and *Lmnb1* alleles. Exons are depicted as black boxes (E1 and E2); the noncoding region of exon 1 is in white. Black arrowheads depict the *loxP* sites. The *neo* cassette is shown as a gray box; a diphtheria toxin (DTA) counterselection cassette is shown as a black box. The primers used for recombineering (GF, GR, LF, and LR) are indicated. The primers used for 5′ long-range PCR (5′ LR-PCR) and 3′ long-range PCR (3′ LR-PCR) are indicated by arrows. (B) Screening of ES cell clones by 5′ long-range PCR. A 7.6-kb fragment was amplified from the *Lmnb2*^B1^ allele; the identity of the fragment was confirmed by *Bgl*II digestion (yielding fragments of 3, 2.2, 1.4, and 1 kb). No product was amplified from wild-type DNA (*Lmnb2*^+/+^). (C) Screening of ES cell clones by 3′ long-range PCR. A 5.77-kb fragment was amplified from the *Lmnb2*^B1^ allele; the identity of the fragment was confirmed with *Bgl*II digestion (yielding fragments of 3.80, 1.64, 0.22, and 0.11 kb (the 0.11-kb fragment ran off the gel and is not seen in this photograph). (D) *Bgl*II digestion of a 706--base pair *Lmnb1* RT-PCR fragment (amplicon from *Lmnb2's* 5′ UTR to exon 4 of *Lmnb1*) from *Lmnb2*^B1/+^ ES cells. The RT-PCR fragment from the *Lmnb2*^B1^ allele was cleaved by *Bgl*II. (E) DNA sequencing chromatogram of an RT-PCR fragment from the *Lmnb2*^B1^ allele showing the junction between the *Lmnb2* 5′ UTR and the *Lmnb1* coding sequences (CDS).](1666fig4){#F4}

In earlier studies, we reported that body weights in *Lmnb2*-knockout mice (*Lmnb2^−/−^*) were normal, but their brains were slightly smaller than in wild-type mice ([@B5]). In the present studies, we found that the body weights of E18.5 *Lmnb2*^B1/B1^ embryos (1.18 ± 0.11 g; *n* = 20) were similar to those of wild-type mice (1.20 ± 0.14 g; *n* = 22; *p* = 0.65); however, the brain weights in *Lmnb2*^B1/B1^ embryos (0.06 ± 0.01 g) were 27.6 ± 0.15% lower than in wild-type embryos (0.09 ± 0.01 g, *p* \< 0.001; Supplemental Table S1). *Lmnb2* transcripts were absent in the cerebral cortex of *Lmnb2*^B1/B1^ embryos (*p* = 0.001), but *Lmnb1* transcript levels in the cerebral cortex of *Lmnb2*^B1/B1^ embryos (*n* = 5) were 70 ± 7.1% higher than in wild-type mice (*n* = 4; *p* = 0.001; [Figure 5A](#F5){ref-type="fig"}). Lamin B2 protein was absent in the cerebral cortex of E18.5 *Lmnb2*^B1/B1^ embryos, but levels of lamin B1 protein were slightly increased ([Figure 5, B and C](#F5){ref-type="fig"}).

![Nuclear lamin expression in the cerebral cortex of E18.5 *Lmnb2*^B1/B1^ embryos. (A) Lamin transcript levels, as judged by quantitative RT-PCR, in the cerebral cortex of *Lmnb2*^+/+^ and *Lmnb2*^B1/B1^ embryos. Transcript levels (mean ± SD) were normalized to cyclophilin A and compared with the levels in *Lmnb2*^+/+^ mice (set at 1.0). *Lmnb1* transcript levels in *Lmnb2*^B1/B1^ embryos were higher than those in *Lmnb2*^+/+^ embryos (*p =* 0.001); *Lmnb2* transcripts were undetectable (*p* = 0.001; *Lmnb2*^+/+^, *n* = 4; *Lmnb2*^B1/B1^, *n* = 5). (B) Western blot of protein extracts from the cerebral cortex of E18.5 *Lmnb2*^+/+^ and *Lmnb2*^B1/B1^ embryos (the same embryos studied in A). (C) Quantification of lamin B1 and lamin B2 protein levels in the Western blot shown in B relative to actin (mean ± SD) and compared with levels in wild-type controls (set at 1.0). Lamin B1 levels in *Lmnb2*^B1/B1^ embryos were higher than those in *Lmnb1*^+/+^ embryos (*p* = 0.039); lamin B2 was undetectable in *Lmnb2*^B1/B1^ embryos (*p* = 0.008).](1666fig5){#F5}

Like *Lmnb2*-knockout mice ([@B5]), *Lmnb2*^B1/B1^ mice died soon after birth. Hematoxylin and eosin--stained sections of the cerebral cortex of *Lmnb2*^B1/B1^ embryos were essentially normal in size ([Figure 6A](#F6){ref-type="fig"}), but there was a neuronal layering defect in the cerebral cortex ([Figure 6, B and C](#F6){ref-type="fig"}, and Supplemental Figure S1)---similar to the pathology in *Lmnb2^−/−^* mice ([@B5]). Immunohistochemistry studies on the putamen confirmed an absence of lamin B2 in *Lmnb2*^B1/B1^ mice ([Figure 6D](#F6){ref-type="fig"}).

![Phenotypes of *Lmnb2*^B1/B1^ mice. (A) Photographs of E18.5 *Lmnb1*^+/+^ and *Lmnb2*^B1/B1^ embryos and their brains. Scale bar, 2 mm. (B) Hematoxylin and eosin--stained sagittal sections of brains from E18.5 embryos. Scale bar, 500 μm. (C) Higher-magnification images of the boxed areas in B, demonstrating abnormalities in the layering of cortical neurons in *Lmnb2*^B1/B1^ mice. Scale bar, 100 μm. (D) Immunofluorescence microscopy of the putamen in E18.5 *Lmnb2*^+/+^ and *Lmnb2*^B1/B1^ embryos with antibodies against lamin B1 (green) and lamin B2 (red). Merged images show DAPI (blue) staining. Scale bar, 50 μm.](1666fig6){#F6}

Intercrosses of mice harboring both knock-in alleles
----------------------------------------------------

We generated mice carrying both knock-in alleles (*Lmnb1*^B2/+^*Lmnb2*^B1/+^) and then intercrossed those mice. No viable *Lmnb1*^B2/B2^*Lmnb2*^B1/B1^ mice were observed by the age of weaning among 207 offspring (*p* \< 0.001 by the chi-squared statistic). Subsequent studies revealed that *Lmnb1*^B2/B2^*Lmnb2*^B1/B1^ mice survived development but died soon after birth. As expected, both lamins B1 and B2 were present in the cerebral cortex of *Lmnb1*^B2/B2^*Lmnb2*^B1/B1^ mice, but the steady-state levels of lamin B1 were only 16.4% of those in wild-type mice ([Figure 7, B and C](#F7){ref-type="fig"}). The levels of lamin B2 in *Lmnb1*^B2/B2^*Lmnb2*^B1/B1^ mice tended to be somewhat lower than in wild-type mice, but this difference was not statistically significant (*p* = 0.16; [Figure 7C](#F7){ref-type="fig"})

![Characterization of *Lmnb1*^B2/B2^*Lmnb2*^B1/B1^ mice. (A) Levels of lamin transcripts in *Lmnb1*^+/+^, *Lmnb1*^B2/B2^, *Lmnb1*^B2/B2^*Lmnb2*^B1/B1^, and *Lmnb1*^−/−^ embryos. Quantitative RT-PCR analysis of *Lmnb1* and *Lmnb2* transcript levels in the cerebral cortex of E18.5 embryos. Transcript levels (mean ± SD) were normalized to cyclophilin A and compared with the levels in wild-type mice (set at 1.0). *Lmnb1* transcript levels in *Lmnb1*^B2/B2^*Lmnb2*^B1/B1^ mice (*n* = 5) were 23.9% of those in wild-type mice (*n* = 4); *Lmnb2* transcript levels in *Lmnb1*^B2/B2^*Lmnb2*^B1/B1^ mice were 51.1% higher than those in wild-type mice; *Lmnb2* transcript levels in *Lmnb1*^B2/B2^ mice (*n* = 6) were 171% higher than those in wild-type mice. (B) Western blot of protein extracts from the cerebral cortex of E18.5 *Lmnb1*^B2/B2^, *Lmnb1*^B2/B2^*Lmnb2*^B1/B1^, and *Lmnb1*^−/−^ embryos and wild-type embryos. (C) Quantification of lamin B1 and lamin B2 protein levels in the Western blot shown in B relative to actin (mean ± SD) and compared with wild-type controls (set at 1.0). Lamin B1 was undetectable in *Lmnb1*^B2/B2^ embryos. Lamin B1 levels in *Lmnb1*^B2/B2^*Lmnb2*^B1/B1^ embryos were only 16.4% of those in wild-type mice. (D) Photographs of E18.5 wild-type, *Lmnb1*^B2/B2^, and *Lmnb1*^B2/B2^*Lmnb2*^B1/B1^ embryos along with the brains from the same mice. Scale bar, 2 mm. (E) Hematoxylin and eosin--stained sagittal sections of brains from E18.5 embryos. Scale bar, 500 μm. (F) Higher-magnification images of the boxed areas in E. Scale bar, 100 μm.](1666fig7){#F7}

Body weights of E18.5 *Lmnb1*^B2/B2^*Lmnb2*^B1/B1^ embryos (0.86 ± 0.11 g; *n* = 5) were similar to those of *Lmnb1*^B2/B2^ embryos (0.86 ± 0.12 g, *n* = 10; *p* = 0.98). However, the brain weights of *Lmnb1*^B2/B2^*Lmnb2*^B1/B1^ embryos (0.06 ± 0.01 g) were 17.9 ± 0.04% higher than in *Lmnb1*^B2/B2^ embryos (0.05 ± 0.01 g; *p* = 0.002) ([Figure 7D](#F7){ref-type="fig"} and Supplemental Table S1). In addition, the pathology in the cerebral cortex of *Lmnb1*^B2/B2^*Lmnb2*^B1/B1^ embryos was less severe than in *Lmnb1*^B2/B2^ embryos (i.e., a higher neuronal density in the cerebral cortex of *Lmnb1*^B2/B2^*Lmnb2*^B1/B1^ embryos; [Figure 7, E and F](#F7){ref-type="fig"}).

In the intercrosses of *Lmnb1*^B2/+^*Lmnb2*^B1/+^ mice, we never observed viable *Lmnb1*^B2/B2^*Lmnb2*^B1/+^ offspring, presumably because of low amounts of lamin B1 production (even lower than in *Lmnb1*^B2/B2^*Lmnb2*^B1/B1^ mice). In contrast, *Lmnb1*^B2/+^*Lmnb2*^B1/B1^ offspring were born at the expected Mendelian frequency and remained healthy and fertile during \>1 yr of observation ([Figure 8A](#F8){ref-type="fig"}). Brain specimens from these mice appeared normal, and microscopic analysis of the cerebral cortex revealed no abnormalities ([Figure 8, B and D](#F8){ref-type="fig"}). The level of lamin B1 expression in *Lmnb1*^B2/+^*Lmnb2*^B1/B1^ mice was greater than half-normal ([Figure 8C](#F8){ref-type="fig"}), reflecting lamin B1 production from two *Lmnb2*^B1^ alleles and one wild-type *Lmnb1* allele. The level of lamin B2 expression in *Lmnb1*^B2/+^*Lmnb2*^B1/B1^ mice was half-normal, reflecting lamin B2 synthesis from a single *Lmnb1*^B2^ allele ([Figure 8C](#F8){ref-type="fig"}).

![Characterization of *Lmnb1*^B2/+^*Lmnb2*^B1/B1^ mice. (A) *Lmnb1*^B2/+^*Lmnb2*^B1/B1^ and wild-type mice at 10 mo of age. (B) Mouse brains from the same mice at 10 mo of age. (C) Western blots of nuclear lamins in tissue extracts from adult *Lmnb1*^B2/+^*Lmnb2*^B1/B1^ and wild-type mice. (D) Hematoxylin and eosin--stained sagittal brain sections of adult mice. Scale bar, 1 mm.](1666fig8){#F8}

DISCUSSION
==========

Lamins B1 and B2 are ubiquitously expressed proteins with a high degree of sequence similarity ([@B33]; [@B7]; [@B4]), and a deficiency of either protein leads to defective neuronal migration in the cerebral cortex ([@B5], [@B6]; [@B36]). These observations naturally elicit a simple question: Are lamins B1 and B2 functionally interchangeable? In the present study, we addressed this question by creating reciprocal knock-in mice (i.e., mice that produce lamin B1 from the *Lmnb2* locus, and mice that produce lamin B2 from the *Lmnb1* locus). Both knock-in mice died soon after birth with neuronal layering abnormalities in the cerebral cortex, demonstrating that increased production of one B-type lamin cannot prevent the developmental defects associated with loss of the other. However, we did find evidence that increased production of one protein led to *partial* amelioration of disease phenotypes. For example, the decrease in body weight and the neurodevelopmental defects in *Lmnb1*^B2/B2^ mice (which produced twofold to threefold more lamin B2 than wild-type mice) were milder than those in *Lmnb1*^−/−^ mice, implying that the supplemental amounts of lamin B2 reduced the disease phenotypes associated with the deficiency of lamin B1. In the case of *Lmnb2*^B1/B1^ mice, the increase in lamin B1 expression was more modest, and the neurodevelopmental abnormalities were similar to those in *Lmnb2*^−/−^ mice ([@B5]). However, the pathology in the cerebral cortex of *Lmnb1*^B2/B2^*Lmnb2*^B1/B1^ embryos was less severe than in *Lmnb1*^B2/B2^ embryos, implying that the modest amounts of lamin B1 from the *Lmnb2*^B1^ allele reduced the severity of the abnormalities elicited by homozygosity for the *Lmnb1*^B2^ allele.

The observation that neither B-type lamin prevents the neurodevelopmental abnormalities elicited by the loss of the other B-type lamin demonstrates that the two proteins play unique and important roles in brain development. With this lesson firmly established, one can, in hindsight, view earlier observations as being consistent with unique functions for the two proteins. For example, [@B6]) showed that deficiencies in lamins B1 and B2 yield distinct morphological abnormalities in cortical neurons. *Lmnb2* deficiency resulted in markedly elongated nuclei but did not affect the distribution of lamin B1 along the nuclear rim, whereas *Lmnb1* deficiency led to solitary nuclear blebs and a markedly asymmetric distribution of lamin B2 (with much of the lamin B2 localized to the nuclear bleb; [@B6]). The distinctive morphological abnormalities in the two knockout lines support distinct functions (and distinct protein--protein interactions) for the two B-type lamins in neurons. Another observation in favor of unique functions for the two proteins is the finding that the farnesyl lipid anchor is extremely important for lamin B1 function but dispensable for lamin B2 ([@B14]). Knock-in mice expressing a nonfarnesylated version of lamin B1 had neuronal migration defects and a unique nuclear abnormality in neurons (the nuclear lamina was pulled away from the bulk of the chromosomal DNA; [@B14]). In contrast, knock-in mice expressing a nonfarnesylated version of lamin B2 were healthy and free of pathology ([@B14]).

*Lmnb1*^B2/B2^*Lmnb2*^B1/B1^ mice exhibited neurodevelopmental abnormalities and died soon after birth. The amount of lamin B1 in the brain of these mice was only ∼16% of that in wild-type mice, and we suspect that the low amounts of lamin B1 expression in these mice were incompatible with normal brain development and survival. However, because all of the lamin B1 in *Lmnb1*^B2/B2^*Lmnb2*^B1/B1^ mice originated from the *Lmnb2* locus, it is conceivable that subtle differences in lamin B1 expression patterns contributed to the developmental defects. In earlier studies, we showed that both *Lmnb1* and *Lmnb2* are expressed in migrating neurons, as judged by β-galactosidase staining ([@B6]). However, the intensity of β-galactosidase staining in the developing brain was much greater in E15.5 *Lmnb1* knockout embryos than in E15.5 *Lmnb2* knockout embryos; the differences in β-galactosidase staining intensity were particularly striking in the ventricular zone, where new neurons are born ([@B6]). In addition, it is conceivable that the absence of introns in the "knocked-in" sequences could perturb gene expression. Intron locations are conserved in vertebrate lamins ([@B17]), but whether introns influence expression patterns is not known. Earlier studies suggest that the sequences immediately upstream to *Lmnb1*'s translational start site may not be entirely responsible for regulating gene expression ([@B18]).

*Lmnb1*^B2/+^*Lmnb2*^B1/B1^ mice survived development and were healthy and fertile. The absence of pathology in these mice demonstrates that lamin B2 functions normally when it is produced under the control of *Lmnb1* gene-regulatory elements. Thus any differences in the spatiotemporal expression pattern conferred by the *Lmnb1* and *Lmnb2* loci are not critical for lamin B2. In hindsight, the survival of *Lmnb1*^B2/+^*Lmnb2*^B1/B1^ mice was not particularly surprising because these mice produce at least half-normal amounts of both lamins B1 and B2. Earlier studies showed that *Lmnb1*^+/−^*Lmnb2*^+/−^ mice, which produce half-normal amounts of both B-type lamins, survive development, are fertile, and are free of neurodevelopmental abnormalities ([@B15]; Coffinier and Young, unpublished data; present study).

The present studies with reciprocal knock-in mice demonstrate that lamins B1 and B2 have unique and vital roles in the developing brain. Increased lamin B1 production does not prevent the disease phenotypes elicited by the loss of lamin B2, and increased lamin B2 synthesis does not prevent the defects associated with lamin B1 deficiency. Our studies also suggest that the amount of lamin B1 expression in the developing brain matters. The ∼16%-normal levels of lamin B1 expression in *Lmnb2*^B1/B1^ and *Lmnb1*^B2/B2^*Lmnb2*^B1/B1^ mice were not sufficient to prevent reduced body weight and neurodevelopmental abnormalities. In contrast, half-normal levels of lamin B1 production in *Lmnb1*^B2/+^*Lmnb2*^B1/B1^ mice were quite sufficient to prevent neurodevelopmental defects.

MATERIALS AND METHODS
=====================

Mice expressing a lamin B2 cDNA from the *Lmnb1* locus and mice expressing a lamin B1 cDNA from the *Lmnb2* locus
-----------------------------------------------------------------------------------------------------------------

We used homologous recombination to introduce a full-length *Lmnb2* cDNA (beginning at the ATG translational start site) into the translational start site in exon 1 of *Lmnb1* (thereby creating a new *Lmnb1* allele, *Lmnb1*^B2^). We also introduced a *Lmnb1* cDNA (beginning at the ATG translational start site) into the translational start site in exon 1 of the *Lmnb2* gene (thereby creating a new *Lmnb2* allele, *Lmnb2*^B1^). The *Lmnb2* and *Lmnb1* cDNAs were from IMAGE clones (IMAGE:5695459 and IMAGE:6816118, respectively). Each cDNA contained two neutral restriction site changes, making it possible to distinguish transcripts from the targeted allele from transcripts originating from the endogenous gene. For the *Lmnb2* cDNA, a new *Eco*RV site was introduced by changing cytosine 168 to adenine with primer 5′-CTC CTC CTT CTC GGA TAT CCG GAG CAG CAA C-3′ (and a complementary primer); a *Sac*I site was removed by changing guanine 852 to adenine with primer 5′-GGC CTC CTT GAG TTC CTC GCG GGC T-3′ (and a complementary primer). Neither change altered the lamin B2 amino acid sequence. For the *Lmnb1* cDNA, a new *Bgl*II site was introduced into the lamin B1 cDNA by changing thymine 381 to adenine with primer 5′-GGG CTC CAC TGA GAT CTG ATT CCT TCT TGG CAT-3′ (and a complementary primer); a *Not*I site was removed by changing cytosine-219 to adenine with primer 5′-GTG AGC TCG CGT CCG CGC ACC TC-3′ (and a complementary primer). Neither change altered the lamin B1 amino acid sequence.

The gene-targeting vectors were generated by BAC recombineering. The *Lmnb1* cDNA was introduced into BAC clone CH38-14G10 (containing *Lmnb2*), and the *Lmnb2* cDNA was introduced into BAC clone CH38-24P17 (containing *Lmnb1*). The cDNAs were introduced in-frame at the translational start site (at an *Nco*I site). The remainder of the vector was constructed by recombineering with primers 5′-AAA CAT TGA CTT TAA CTG CAG AGA TGG CGC AAC GCA ATT AAT G-3′ and 5′-GGT CTG AGC TCG CCA TCA GTT CAG AGC GCG CCA AGC TCC AGA TCG AGC TGG GCA AGT TCA AGG CCG AGC ACG A-3′ (to introduce the *lox*P-*Neo*-*lox*P cassette into *Lmnb1*^B2^) and primers 5′-CAA ATA AAA CGC TGT TTT CCG ATA TCG AGA TGG CGC AAC GCA ATT AAT G-3′ and 5′-CGA GTG GTC ACC TCC TCC TTC TCG GAG ATC CGG AGC AGC AAC CTA TCA TTT GAA CTG ATG GCG AGC TCA GAC C-3′ (to introduce the *lox*P-*Neo*-*lox*P cassette into *Lmnb2*^B1^). Gap-repair primers 5′-TCT AGA CGT TTC TGT AAG GCG TCC AGG TGG CGT TTA ATT TCA GTC AAC AG-3′ and 5′-GGT CTG AGC TCG CCA TCA GTT CAG AGC GCG CCA AGC TCC AGA TCG AGC TGG GCA AGT TCA AGG CCG AGC ACG A-3′ were used for *Lmnb1*^B2^; gap-repair primers 5′-TGG GAG GCT AGC AGC CCC TTT TGT AGT TAG TCA GGG CAC ACC TGG CTG TT-3′ and 5′-GAC ACC ACC TGT CCA TGC AGG TGA CGG TGG CAA AGT CCA CTT TGG TTT CT-3′ were used for *Lmnb2*^B1^. The *Lmnb1*^B2^ vector contained a 4.9-kb 5′ arm followed by *Lmnb2* coding sequences and 3′ UTR (replacing *Lmnb1*'s exon 1 starting at the ATG); the *lox*P-*Neo*-*lox*P selection cassette; a 3.1-kb 3′ arm; and a diphtheria toxin (DTA) cassette for negative selection. The *Lmnb2*^B1^ targeting vector contained a 5.2-kb 5′ recombination arm followed by *Lmnb1* coding sequences and 3′ UTR (replacing *Lmnb2*'s exon 1 starting at the ATG); the *lox*P-*Neo*-*lox*P selection cassette; a 3.4-kb 3′ arm; and a DTA cassette for negative selection.

All intron--exon junctions in the targeting vector were verified by DNA sequencing. After linearization with I-*Sce*I, the vectors were electroporated into E14Tg2A ES cells. After selection with G418 (125 μg/ml; Life Technologies, Invitrogen, Carlsbad, CA), ES cell colonies were picked and screened for recombination on the 5′ end by long-range PCR (2× Extensor Long Range PCR Master Mix; Thermo Scientific, Waltham, MA) using primers 5′-CAA CCT GCA GGC TTT CAT TAG CTC T-3′ and 5′-CCT CCT CAA ACA CAC TCT TGC TGA A-3′ for the *Lmnb1*^B2^ allele and primers 5′-AAT GCC CTA CCC ACT GCT CCT AAA T-3′ and 5′-GCT TGA GGA AGA TCG ACC ATG TCT T-3′ for the *Lmnb2*^B1^ allele. Targeted clones were then further analyzed by long-range PCR on the 3′ end using primers 5′-GTG GAG AGG CTA TTC GGC TAT GAC T-3′ and 5′-AGT CGA TCT CTG TCT GAG GCC AGT T-3′ for the *Lmnb1*^B2^ allele and primers 5′-GTG GAG AGG CTA TTC GGC TAT GAC T-3′ and 5′-AGG AAT CCT CTG CCT CCT GAG AGT T-3′ for the *Lmnb2*^B1^ allele. The products of the 5′ and 3′ long-range PCRs were further verified by restriction endonuclease digestion, taking advantage of the new restriction endonuclease sites in the targeted alleles.

Expression of lamin B2 from the *Lmnb1*^B2^ allele was verified by RT-PCR using primers 5′-AGA AGG AGG AGC TCC GTG A-3′ (from *Lmnb2* exon 1 sequences after the ATG) and 5′-CAC CTC CGT CAT CTC CTG TT-3′ (from *Lmnb2* exon 7 sequences). The resulting 950--base pair DNA fragment was cleaved by *Eco*RV into 100-- and 850--base pair fragments. The DNA amplified from the wild-type allele was not cleaved because it did not contain the *Eco*RV site. Expression of lamin B1 from the *Lmnb2*^B1^ allele was verified by RT-PCR with primers 5′-GGC AAC CGA GGT GAT TCT C-3′ (from *Lmnb2's* 5′ UTR) and 5′-GGT CTC ATG CTT CCT CCT TG-3′ (from *Lmnb1* exon 4 sequences) for *Lmnb2*^B1^. The resulting 706--base pair product was cleaved by *Bgl*II into 296-- and 410--base pair fragments. Full-length cDNAs from targeted ES cells were sequenced to verify that no additional mutations were introduced. After verifying that the ES cells were euploid, two independently targeted ES cell lines were injected into C57BL/6 blastocysts. Male chimeras were mated with C57Bl/6 females to generate heterozygous mice (*Lmnb1*^B2/+^ and *Lmnb2*^B1/+^).

Mice harboring *Lmnb1*^B2^ and *Lmnb2*^B1^ alleles were genotyped by PCR. The wild-type *Lmnb2* allele was identified by amplifying a 396--base pair product with primers 5′-AGA AGG AGG AGC TCC GTG A-3′ and 5′-GGC TTC AGC GTT ATG CAT CT-3′; the *Lmnb2*^B1^ allele was identified by amplifying a 317--base pair product with 5′-GTC TGA GCT CGC CAT CAG TT-3′ and the same reverse primer. The wild-type *Lmnb1* allele was identified by amplifying a 441--base pair product with primers 5′-TGC AGG AGA AAG AGG AGC TG-3′ and 5′-GGC ACC CCT GTT CAG TTC TA-3′; the *Lmnb1*^B2^ allele was identified by amplifying a 256--base pair product with primer 5′-GTC TGA GCT CGC CAT CAG TT-3′ and the same reverse primer.

All mice were fed a chow diet and housed in a virus-free barrier facility with a 12-h light/dark cycle. The UCLA Animal Research Committee approved all animal protocols.

Knockout mice
-------------

The *Lmnb1*-knockout mice (*Lmnb1*^−/−^) used in this study were generated by breeding mice homozygous for a *Lmnb1* conditional knockout allele (*Lmnb1*^fl/fl^; [@B34]) with mice harboring an Ella*-Cre* transgene ([@B2]). The *Cre*-mediated recombination event deleted exon 2 of *Lmnb1*, resulting in a null allele. Unlike the *Lmnb1*-knockout mice described earlier ([@B31]), the *Lmnb1*^−/−^ used here did not produce a *Lmnb1--lacZ* fusion protein.

Western blots
-------------

Mouse tissues were prepared as described ([@B8]; [@B9]; [@B13]). Snap-frozen mouse tissues were pulverized with a chilled metal mortar and pestle, resuspended in ice-cold phosphate-buffered saline, and homogenized with a glass tissue grinder as previously described ([@B14]). The cell pellets were resuspended in urea buffer, sonicated, and centrifuged to remove cell debris. SDS--PAGE was performed on a 4--12% gradient polyacrylamide Bis-Tris gel, transferred to nitrocellulose membranes, and incubated with the following antibodies: a goat polyclonal antibody against lamin A/C (sc-6215; Santa Cruz Biotechnology, Santa Cruz, CA), a goat polyclonal antibody against lamin B1 (sc-6217; Santa Cruz Biotechnology), a mouse monoclonal antibody against lamin B2 (33-2100; Invitrogen), and a goat polyclonal antibody against actin (sc-1616; Santa Cruz Biotechnology). Binding of primary antibodies was assessed with infrared dye--conjugated secondary antibodies (Rockland Immunochemicals, Boyertown, PA) and quantified with an Odyssey infrared scanner (Li-Cor Biosciences, Lincoln, NE).

Quantitative RT-PCR
-------------------

Snap-frozen mouse tissues were homogenized in TRI reagent (Molecular Research Center, Cincinnati, OH); total RNA was extracted and treated with DNase I (Life Technologies, Ambion). RNA was then reverse transcribed with random primers, oligo(dT), and SuperScript III (Invitrogen). Quantitative PCRs were performed on a 7900 Fast Real-Time PCR system (Life Technologies, Applied Bio­systems) with SYBR Green PCR Master Mix (Bioline, Taunton, MA). Transcript levels were determined by the comparative cycle threshold method and normalized to levels of cyclophilin A.

Histology and immunofluorescence microscopy
-------------------------------------------

Mouse tissues were fixed in 10% Formalin (Evergreen, Los Angeles, CA), embedded in paraffin, sectioned (5-μm thick), and stained with hematoxylin and eosin. For immunohistochemical staining, mouse tissues were embedded in Optimum Cutting Temperature compound (Sakura Finetek, Torrance, CA) and cut into 8-μm-thick sections using a cryostat. Sections were fixed in ice-cold methanol, rinsed with acetone, washed with 0.1% Tween-20 in Tris-buffered saline, and incubated with M.O.M. Mouse Ig Blocking Reagent (Vector Laboratories, Burlingame, CA). The following primary antibodies were used: a goat polyclonal antibody against lamin B1 (sc-6217; Santa Cruz Biotechnology), a mouse monoclonal antibody against lamin B2 (33-2100; Invitrogen), a rat monoclonal antibody against Ctip2 (ab18465; Abcam, Cambridge, MA), and a rabbit polyclonal antibody against CDP (sc-13024, Santa Cruz Biotechnology). Alexa Fluor--labeled donkey antibodies against goat, mouse, rat, or rabbit immunoglobulin G (Invitrogen) were used to detect binding of primary antibodies. DNA was stained with 4′,6-diamidino-2-phenylindole (DAPI).

Light microscopy images were obtained with a Leica MZ6 dissecting microscope (Plan 0.5× objective, air) or a Nikon Eclipse E600 microscope (Plan Fluor 2×/0.1 numerical aperture \[NA\] or 10×/0.2 NA objective, air) with a Digital Sight DS-Fi2 camera (Nikon, Tokyo, Japan). The images were captured with Leica Application Suite imaging software and NIS-Elements F4.00.00 (Nikon), respectively. Confocal fluorescence microscopy was performed with a Zeiss LSM700 laser-scanning microscope with a Plan Apochromat 20×/0.80 NA objective (air).

Statistical analyses
--------------------

Statistical analyses were performed with Excel for Mac 2011 (Microsoft, Redmond, WA). Differences in expression levels of lamins B1 and B2 and differences in body weights and brain weights were analyzed by a two-tailed Student\'s *t* test. Chi-squared tests were performed with Excel for Mac 2011.
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